Non-Invasive Technologies for Continuous Hemodynamic Monitoring in Clinical Use are on the Rise
2024 17 May
The Executive Board of the German Society for Anesthesiology recently adopted a new guideline that addresses the intraoperative clinical application of hemodynamic monitoring in non-cardiac surgical patients. 1 Why continuous hemodynamic monitoring? The aim of this special guideline was to identify the questions that are important...Read more
Nova Biomedical New Generation StatStrip Glucose Hospital Meter Obtains FDA 510k Clearance
2024 15 May
Nova Biomedical announces the U.S. launch of our New Generation StatStrip Glucose Hospital Meter System. The new meter includes many features that make hospital glucose testing easier and more cybersecure while retaining the accuracy, freedom from interferences, and FDA clearance for use with critically ill patients that StatStrip has provided...Read more
Philips Announces Q1 Results Aligned with 2024 Plan, Settles Respironics Litigation for $1.1 Billion
2024 29 Apr
First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 billion Respironics litigation settlement reached in the US (provision recognized of EUR 982 million) Income from operations EUR -824 million, including...Read more
Masimo Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
2024 22 Mar
Masimo , a global leader in noninvasive monitoring technologies and audio products, today announced that its Board of Directors has authorized management to evaluate a proposed separation of its consumer business. The Board and management will evaluate the proposed structure of the separation. Masimo expects that the separation will include its...Read more
Shaping Kidney Care: Fresenius Medical Care 2023 Annual & Sustainability Report
2024 22 Mar
Fresenius Medical Care delivers on commitments during a year of fundamental transformation Progress towards sustainability goals in key areas: patient satisfaction, diversity in management, climate target roadmap Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with renal diseases,...Read more
Fresenius Medical Care: “Augmented Reality” for training on Kidney Replacement Therapy device
2024 19 Mar
For the first time, Fresenius Medical Care develops and utilizes “Augmented Reality” (AR) to train medical staff in Intensive Care Units (ICUs) The new training application for ICU staff combines digital learning elements with real-life training on the Fresenius Medical Care Continuous Kidney Replacement Therapy system This learning experience...Read more
Acadia Hospital welcomes Kristen Sparks, MD to Consult Services
2024 12 Mar
Kristen Sparks, MD recently joined the Consult Services team at Northern Light Acadia Hospital. In her new role, Dr. Sparks will provide high level psychiatric assessments and treatment recommendations to providers at 22 emergency departments across the State of Maine. Dr. Sparks attended Ohio State University where she earned her medical...Read more
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
2024 07 Mar
Masimo Stork™ and Bowers & Wilkins Garner Six Prestigious Accolades Across Multiple Categories Masimo is proud to celebrate multiple wins across various categories at the prestigious iF DESIGN AWARDS 2024, showcasing its commitment to excellence in design and innovation throughout diverse industries. With an impressive 11,000...Read more
Fresenius Medical Care Portfolio Optimization Announcing Sale of Dialysis Clinics
2024 05 Mar
Divestment of assets includes four separate country transactions to DaVita Inc. for USD 300 million Transactions further reduce the Company`s clinic footprint in Latin America, following the exit from Argentina at the end of 2023 Expected to close throughout 2024 Proceeds to be used to reduce debt Fresenius...Read more
Rare Diseases: No Innovative Therapies Without Research
2024 20 Feb
Individualized therapies and the integration of the patient's perspective are becoming increasingly important. February 29 is Rare Disease Day. On this occasion, the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health) takes a look at the challenges faced by patients with rare diseases and highlights the trends...Read more
Masimo SET® Pulse Oximetry Accurate Across Black & White Subjects, Even in Low Perfusion
2024 08 Feb
Masimo announced the findings of a retrospective, peer-reviewed study published in the Journal of Clinical Monitoring and Computing in which Dr. Vikrant Sharma, along with Dr. Steven J. Barker, Dr. William C. Wilson, and colleagues at Masimo performed a focused analysis of previously published data to evaluate the impact of low perfusion on...Read more
Fresenius Medical Care Introduces Leading Dialysis Therapy for U.S. Kidney Patients
2024 08 Feb
Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s 5008X Hemodialysis System. This will enable Fresenius Medical Care to offer the industry-leading, high-volume hemodiafiltration (Hv-HDF) dialysis therapy – already widely used in Europe – for people living with kidney diseases...Read more
AOP Health Receives Market Authorization for Landiolol in Canada
2023 13 Dec
At the end of November 2023, AOP Orphan Pharmaceuticals GmbH ( AOP Health ), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada) for its ultra-short-acting, cardioselective β1-blocker Landiolol. The drug is used in intensive care to treat atrial fibrillation and atrial flutter...Read more
Planned EU Pharmaceutical Legislation Could Complicate Development of Rare Disease Therapies
2023 12 Dec
The entire EU pharmaceutical legislation is currently being negotiated. Among the regulations to be redefined are those concerning rare diseases. Experts fear that the planned changes – in particular by shortening protection periods – will lower the incentive for companies to conduct research in the field of rare diseases. This would reduce the availability...Read more
Blood Cancer: AOP Health Announces New Findings in Patients with Polycythemia Vera
2023 07 Dec
Presented at the American Society of Hematology (ASH) 65th annual meeting AOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treatment response in patients with low-risk polycythemia vera (PV) 1 These...Read more
Introducing Hamilton Medical's VenTrainer - A Mobile Application Redefining Ventilation Training
2023 05 Dec
Ventilation management is a critical aspect of patient care, and staying at the forefront of this discipline is paramount for healthcare professionals. Hamilton Medical recognizes this need for innovative training tools and is excited to introduce the VenTrainer app, which enables new training opportunities in the world of mechanical ventilation....Read more
Collaborative Research Ensures Availability of Rare Disease Therapies
2023 14 Nov
To ensure the availability of new therapies for rare diseases, a functioning cooperation between the public sector, academic research and research-based companies is crucial. With this in mind, Vienna's City Councilor for Health, Social Affairs and Sport, Peter Hacker, paid the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH ("AOP Health")...Read more
Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China
2023 26 Oct
Fapon, a leading life sciences company, entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. This strategic partnership will enable Fapon to engage in the research, development,...Read more
Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
2023 09 Oct
LiDCO Offers Clinicians, for the First Time, a Board-in-Cable Solution Designed to Provide a More Complete Picture of Oxygen Delivery Masimo announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO ® board-in-cable (BIC) module. The LiDCO BIC module is designed to connect to multi-patient monitoring platforms,...Read more
Getinge Completes Acquisition of High Purity New England, Inc.
2023 04 Oct
Getinge has completed the previously announced acquisition of 100% of the shares in High Purity New England, Inc. On May 31, 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. All conditions...Read more
FDA Clears Nova’s Stat Profile Prime Plus Analyzer for Micro Capillary Sample Mode
2023 03 Oct
Nova Biomedical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a micro capillary sample mode on the Stat Profile Prime Plus® Critical Care analyzer. Prime Plus now performs an 11-test panel including pH, PCO2, PO2, Na, K, iCa, iMg, Cl, glucose, lactate, and hematocrit with just 90 microliters...Read more
World Sepsis Day: Understanding Symptoms Better
2023 08 Sep
World Sepsis Day falls on September 13. Sepsis, which kills more people in Austria each year than heart attacks, is caused by an infection which spreads through the body and damages our organs. A lot of people in the general public still do not know very much about this issue. Sepsis is one of the most common causes of death around the world....Read more
Health In Tech Introduces New Ancillary Products to Expand Healthcare Solutions
2023 06 Sep
Expands Health Care offerings with Critical Illness, Accident, Dental, Vision, Term Life, and GAP coverage options. Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans, is excited to introduce additional Healthcare products to address customers’ needs holistically....Read more
Debiopharm Joins With International Health Organisations to Fight Anti-Microbial Resistance
2023 06 Sep
The rapid growth of antimicrobial resistance (AMR) is staggering, particularly when considering the slow rate at which new antibiotics are being developed and made available to patients 1 International health authorities, including the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), continue...Read more
Mindray Introduces Innovative Upgrades to A Series Anesthesia Systems
2023 30 Aug
Mindray has unveiled exciting upgrades to its A7 and A5 anesthesia systems under the A Series Anesthesia. The brand-new enhancements incorporate innovative technologies that empower anesthesiologists to deliver precise anesthesia, leading to greater patient safety and efficiency throughout the perioperative period. The demand for high-quality...Read more
Sustainability at Hamilton Medical
2023 20 Jun
The first sustainability report for the year 2022 is out, covering our concept, actions, and goals for combining value creation with social justice and ecological responsibility. Economic success is important for every company, but so is the future. The Hamilton group started measuring its total carbon footprint in 2021 and has set targets...Read more
Neonatal and Pediatric ECMO with Minilung Petite Kit
2022 02 Nov
Fresenius Medical Care heart & lung launches patient kit, especially for neonatal and pediatric ECMO use Fresenius Medical Care’s heart & lung division Xenios AG introduced the MiniLung petite kit at ESICM LIVES congress this October. This patient kit was developed especially for neonatal and pediatric ECMO. Fresenius Medical Care’s heart...Read more
Getinge Expands its Virtual Hospital to Add More Value for Visitors
2022 27 Oct
Since the opening in 2021, Getinge’s Virtual Hospital has offered visitors to experience hospital solutions in different rooms. The online facility is now coming together as a whole, with entire hospital departments allowing visitors the full picture of how the MedTech suppliers broad range of solutions work together throughout the clinical pathway....Read more
Fresenius Medical Care Heart and Lung Enables ECMO Simulation in Virtual Reality
2022 25 Oct
VR app for extracorporeal heart and lung support at ESCIM LIVES 2022 Fresenius Medical Care’s heart & lung division Xenios AG presents its virtual reality application at ESCIM LIVES congress in Paris. Visitors can discover a fictitious ECMO case and interactive hands-on experiences. Fresenius Medical Care’s heart & lung division Xenios...Read more
Merger: Medos Becomes Fully Integrated Within Xenios AG
2022 01 Sep
Medos Medizintechnik AG was merged into Xenios AG. This streamlines processes within the company and at the same time it grows closer to the parent company Fresenius Medical Care AG & Co. KGaA. Medos Medizintechnik AG (Medos) was founded in 1987 with a focus on cardiopulmonary solutions. Together with Novalung GmbH (Novalung), the company...Read more
